FDA 483 - CIT Ortho - September 05, 2023

CIT Ortho, a medical device manufacturer in Westlake, OH, received two observations during an FDA inspection. The firm's complaint handling procedures were found to be inadequately established, lacking defined priority levels and clear investigation requirements. Additionally, their design change procedures were deficient, as required documentation and impact assessments were not routinely completed or justified.